A phase II trial of PS-341 (NSC-681239) [bortezomib] in patients with platinum-treated extensive-stage small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2013
At a glance
- Drugs Bortezomib (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 10 Jul 2007 Status changed from in progress to completed.
- 17 Aug 2006 Status change
- 18 Sep 2005 New trial record.